Jessica Keim-Malpass, PhD, RN

Jessica Keim Malpass is a nurse scientist and pediatric hematology-oncology nurse practitioner. She received her Ph.D. in Nursing Science from the University of Virginia and has completed additional graduate degrees in advanced practice pediatric nursing, regulatory science, clinical epidemiology, and health economics/pharmacoeconomics.

Dr. Keim-Malpass’s research includes translational science, economics, and computational methods that support evidence integration in precision medicine to allow patients, families, clinicians, and health systems to make decisions about novel therapeutics with an equity-oriented approach. Populations she works with include adolescents, children, and young adults with medical complexity and severe illness and those with a hematological or cancer diagnosis. 

Alongside CoMET creator Dr. Randall Moorman, Dr. Keim-Malpass conducted research for analytics software for the early detection of imminent catastrophic illness, CoMET, leading the introduction of UVA’s Surgical and Trauma ICU. She also partnered with Dr. Jamie Bourque to conduct a large R01-funded clinical trial assessing the effectiveness of CoMET implementation across acute care wards. She has authored papers detailing the importance of AI-based technologies for nurses treating patients with rapid deterioration with COVID-19. She currently leads the Dissemination and Implementation core efforts at iThriv, an NIH-funded cross-state collaboration between UVA, Virginia Tech, Inova, and Carilion Clinic. She was recognized as a National Academy of Medicine Scholar in Diagnostic Excellence in 2021 and inducted as a Fellow of the American Academy of Nursing in 2022.